April 2004 - Taclist - mailman.xmission.com

We give this recommendation a significant upgrade b
by Lincoln Saunders 13 Apr '04

13 Apr '04

LETH******LETH******LETH******LETH******LETH Maximum Financial Stock Alert Life Energy and Technology Holdings (OTCBB: LETH) Recent Price: 1.90 52 Week Range: 0.78 - 2.95 Avg. Volume (100 days): 198,099 LETH, a manufacturer of environmentally friendly waste-to-energy conversion systems, has filed the required Form 8-K with the SEC disclosing that the Company has received $250,000,000 in financing! This funding package translates into $8.62 per share in cash for major worldwide expansion. LETH is firmly establishing a major US presence with the installation of the Company's Biosphere Process System at the Port of New Orleans during this current quarter. The opening of this facility will be hailed as a milestone achievement complete with intense media coverage and the attendance of prominent local and national political figures who have paved the way for this ground- breaking event. Key Investment Fact: LETH has received sales orders during the past year of over $100 million! Since Jan. 1, 2004 the overall market value of our picks has increased by $Millions$! Here at Maximum Financial, our stock picks are up over 348% on average in 2004! 7-Day Target: 3.40 30-Day Target: 5.70 1YR Target: 12.50 Examining LETH - By The Numbers: Total Assets: 36.8 Million = 1.26 per share of assets Cash: 23.4 Million = .80 cents per share of cash Shares Outstanding: 29 million (down from 31.8 million) after 2.8 million shares retired in Feb. '04 Additional Shares to be Retired: 1.3 million per Company press release Estimated Shares in Float: 7 million Completed Biosphere Process Systems Now in Operation: 26 Potential Size of Market (US/Foreign): Too Large To Calculate (Unlimited) Solving a Dual Crisis - Waste and Energy: LETH is utilizing the unique proprietary technology of their Biosphere Process System to generate revenue from the disposal of a wide variety of waste products at 5 to 7 tons per hour which makes a major impact on the global waste problem. This profitable and environmentally safe process converts into clean, "green" electricity such waste materials as Municipal Solid Waste, agricultural wastes, forestry wastes, medical wastes, industrial wastes, sewage sludge, shale oil, sour natural gas, and the huge market of used tires. LETH profits from the sale of electricity created from the waste conversion on a continuous basis by generating 5 to 10 mega- watts per hour of electricity which is then sold to replenish the local or national grid. Record Backlog of Sales for LETH: During the past year, over 20 Biosphere Process Systems have been ordered, which upon completion represents a backlog exceeding over $100 Million in upcoming sales. Many of these contractual agreements include options for the purchase of additional Biosphere Systems in the future once the initial order has been completed. The options vary from hundreds to thousands of units per contract which would send shockwaves through this low-float, emerging industry leader at an average sale price of $7 Million per Biosphere Process System! Financing of $250 Million Positions LETH for Astronomical Sales: The magnitude of this financing package goes much deeper than the fact that LETH trading at around $2.00, now has accessible capital equivalent to $8.62 per common share in cash. There are 26 Biosphere Process Systems presently in operation worldwide. The available funding could easily be used to produce 100 additional Biospheres. Now factor in that the average sale price is $7 Million per Biosphere. We cannot even comprehend what this stock should be trading for with a potential $700,000,000 in future sales with 29 million shares outstanding! Political Power Fosters Rapid Global Expansion: LETH has captured the profit-making attention of both US and international investors by embracing a major foothold on the global waste problem as well as the urgent need to generate electricity from alternative sources. This has been accomplished by successfully creating major inroads to all corners of the globe through the political contacts at the highest level from Dr. Albert Reynolds, Chairman of LETH, who is also the former Prime Minister of Ireland. Dr. Reynolds international stature has been instrumental in guiding LETH into a position of worldwide dominance in an industry with such high global demand that it is impossible to assign a value to the size of the market. Uncommon Value for a Company of this Caliber: We are witnessing a breakout year in the making judging by the frequency of recently announced sales contracts for the Biosphere, the impressive backlog of over $100 Million in sales orders, and the Company's very solid financial position. We view this perfectly timed convergence of events as the catalyst for additional contracts that will perpetuate the shattering of the Company's own sales records. We anticipate the continuation of strong positive developments encompassing a major boost when the first unit is rolled-out in New Orleans that will ignite LETH shares. LETH carries our highest rating for short-term trading profits followed by robust long-term capital gains for aggressive portfolios looking for homerun performance. Maximum Financial Stock Alert (MFSA) cautions that small and micro-cap stocks are high-risk investments and that some or all investment dollars can be lost. We suggest you consult a professional investment advisor before purchasing any stock. All opinions expressed on the featured company are the opinions of MFSA. MFSA recommends you use the information found here as an initial starting point for conducting your own research and your own due diligence on the featured company in order to determine your own personal opinion of the company before investing. MFSA is not an Investment Advisor, Financial Planning Service or a Stock Brokerage Firm and in accordance with such is not offering investment advice or promoting any investment strategies. MFSA is not offering securities for sale or solicitation of any offer to buy or sell securities. MFSA has received forty thousand dollars from an unaffiliated third party for the preparation of this company profile. Since we have received compensation there is an inherent conflict of interest in our statements and opinions. Readers of this publication are cautioned not to place undue reliance on forward looking statements, which are based on certain assumptions and expectations involving various risks and uncertainties, that could cause results to differ materially from those set forth in the forward looking statements. jhtewpgiq rtzc ejdmjbu xydjmkybf pexvh rpng rdvia u

1 0

Rock Solid Erect.ions In 60 Seconds!
by Tmustelin 13 Apr '04

13 Apr '04

1 0

HealthCare Sector/Medical Technologies - AMTK Exclusive Contracts, Tue, 13 Apr 2004 06:32:00 -0500
by Freda Kerr 13 Apr '04

13 Apr '04

Equity Spoltight - Tue, 13 Apr 2004 06:32:00 -0500 Symbol: AMTK - Austin Medical Technologies Sector: HealthCare/Medical Technologies AMTK - On the Cutting Edge of Medical Technologies AMTK is experiencing strong and sturdy growth due to the continued demand for its products and services utilized by surgeons throughout the world. The business is an annuity model with recurring revenue each month. Customers sign multi-year contracts, and AMTK maintains a track record of 95% contract renewal. AMTK delivers "DIRECT" from the manufacturer to the surgeon, the only technology-based "Single Source Supply Solution" serving the Ambulatory Surgery Center (ASC) market. Under the brand name eyeDirecti, AMTK is initially focused on surgeon-owned and operated ASCs which consist of 2,500 practices with 15,000 surgeons performing 4.4 million surgical procedures annually at a supply cost of 400 million dollars per year. HIGHLIGHTS 1) AMTK has exclusive contracts with leading HealthCare companies such as Baxter, Medtronic, Allergan, and OcuSoft. 2) AMTK is a manufacturer and distributor of several hundred medical and surgical products -- enough to fill 80 percent of a typical ASC's supply needs. 3) AMTK provides products and services exclusively to the 2500 Ophthalmology-owned and operated Ambulatory Surgery Center (ASC) market, which is the fastest growing segment of HealthCare with over 10 million surgical procedures performed annually. AMTK is focused on providing disposable surgical supplies and superior service to this outpatient HealthCare provider. 4) AMTK's founders have more than 100 years' experience in the ophthalmic surgical products and technology industries. AUSTIN MEDICAL TECHNOLOGIES, Inc. AMTK provides hundreds of products and technology-based services needed by ASC's. AMTK offers disposable surgical instruments, custom sterile procedure packs, intravenous solutions, patient care supplies, and technology to enhance efficiencies and eliminate cost to the customer. AMTK's in-depth knowledge concerning special interactions among ASC's and manufacturers has driven it to create the surgical eye care supply chain and e-commerce solution that dramatically simplifies the distinctive methods and processes used byits customers to manage their business. AMTK has exclusive contracts with leading HealthCare companies such as Baxter, Medtronic, Allergan, and OcuSoft for manufacturing and distribution of the products it markets. This is key: AMTK provides not just products but also a unique set of innovative, integrated cost-management services. These are extremely important in HealthCare today; they allow ASC's to save money and focus on patient care rather than supplies and logistics. Customer Requirements Every year 10 million surgical procedures are performed within the ophthalmic ASC market. Every day there are more than a million people making outpatient visits to medical centers across the country. The nation spends about a trillion dollars a year -- a sixth of its total economy -- on HealthCare. That amount continues to grow as the population ages and new medical capabilities develop. Globally, HealthCare is a large, vital, growing industry. How Austin Medical Technology Responds More than any other company in HealthCare, AMTK can help ophthalmic ASC's manage their costs and their resources. AMTK can address the 20-plus percent of an ASC budget that goes for supplies and the additional 20 percent or more that very often is devoted to managing those supplies. AMTK is a manufacturer and distributor of several hundred medical and surgical products -- enough to fill 80 percent of a typical ASC's supply needs. More important, AMTK integrates its total product-offering with unique services that have been proven to help control HealthCare costs. AMTK helps its customers purchase and use fewer supplies. AMTK helps them order and manage inventories more efficiently. Custom Procedure Trays (CPT's) aka "packs" incorporate 70-80% of disposable surgical supplies utilized on a procedure specific basis. CPT's is a 2 billion dollar industry HealthCare wide and $400 million within the ophthalmic ASC market. 95% of ophthalmologists utilize packs for Cataract, Retinal and Plastic procedures. LASIK packs are now being created for this new procedure. Stock Market Watcher is an independent research firm. This report is based on Stock Market Watcher's independent analysis but also relies on information supplied by sources believed to be reliable. This report may not be the opinion of CYPM management. Stock Market Watcher has also been retained to research and issue reports on CYPM. Stock Market Watcher may from time to time purchase or sell CYPM common shares in the open market without notice. The information contained in this report shall not constitute, an offer to sell or solicitation of any offer to purchase any security. It is intended for information only. Some statements may contain so-called "forward-looking statements". Many factors could cause actual results to differ. Investors should consult with their Investment Advisor concerning CYPM. Copyright 2004 © Stock Market Watcher Ltd. SMS, Apartado 173-3006 Zona Franca MeoBarreal Heredia, Costa Rica. All Rights Reserved. This newsletter was distributed by MMS,Inc. MMS was paid four thousand dollars to distribute this report. MMS is not affiiated with Stock Market Watcher and is not responsible for newsletter content. No more ads, cheretaormina(a)inbox.lv rna hernandez wisconsin ahmedabad wing country culture shimmy gilt divide adduce zeroes glamor excretory whomever cornea tachinid chevalier disc norm dubhe blade ana beatrice ellipsoid makeshift cambric crumb delectable m's deed harvestman crumble couldn't atrophy camelopard counterman improbable alumnae bonfire appeasable mathews emphysematous barr sheet denture advent grippe huston testament nutritious duct acapulco brandeis complementarity unicorn despotic apostrophe shriek

1 0

Online Pharmacy Price Guide
by Bret Harrison 12 Apr '04

12 Apr '04

1 0

The 2004 edition of The American Medical Directory plastic surgery, oncology. bybofhncb
by Will Franco 11 Apr '04

11 Apr '04

Subjects: physicians, specialists, doctors, licensed doctors, board physicians, emergency physicians, 2004 physicians guide, 2004 physicians directory, physicians contact. EXCLUSIVELY ON CD-ROM. The 2004 edition of The American Medical Directory & Physicians Guide has just been completed. According to many librarians, it is one of the most referenced and frequently-used publication in libraries throughout the United States. It is also used by most healthcare professionals and industry business development executives. The American Medical Directory & Physicians Guide contains relevant data on over 500,000 physicians in the United States. Each record is indexed by such features as name, address, phone/fax, county, year licensed, type of practice, type of physician, as well as primary and secondary specialty. During this introductory offer, the cost of the new directory (which is available exclusively on CD-Rom) is $375.00 (reg. $795). The CD-Rom is in Excel format and is searchable, downloadable, and can be used on an unlimited basis. To order the American Medical Directory & Physicians Guide, please print this e-mail, complete the information below and fax it to 905-751-0199. (tel: 905-751-0919). BONUS OFFER: ORDER NOW AND RECEIVE THE AMERICAN NURSING HOME DIRECTORY ON CD-ROM FREE OF CHARGE. NAME: TITLE: ORGANIZATION: ADDRESS: CITY: POSTAL: TEL: FAX: E-MAIL: InfoSource Group of Companies is a leading information publishing firm with offices throughout North America and Europe. e prti obcsk cuwarzgv q hofw rfdzko yd oa kxt fy jzj uppeyrxk ionk a hgqccw wr

1 0

Stock on the move, jump in on the ground floor gwsjkj rrrdkylicvq
by Ella Starnes 11 Apr '04

11 Apr '04

April 2004 Top Pick of the Month Life Energy and Technology Holdings, Inc. (OTCBB: LETH) LETH Receives $250,000,000 in Financing to Fund the Manufacture of the Environmentally Friendly Biosphere Process System "waste-to-energy" Units in the United States. First Unit to Roll-out in New Orleans in early Second Quarter. We are expecting earth-shattering upcoming news leading a strong rally in LETH for a Company that has announced over $100 Million in sales orders in the past year, and tops that record-setting achievement by acquiring the equivalent of $8.62 per share in cash for major worldwide expansion. **Our readers grabbed substantial profits for our March pick** USHG featured at .75 Reached 3.65 in 8 days! Traded as high as 7.00 since! The Biosphere Process System - Soaring Worldwide Demand: LETH is utilizing the unique proprietary technology of their Biosphere Process System to generate revenue from the disposal of a wide variety of waste products at 5 to 7 tons per hour which makes a major impact on the global waste problem. This profitable and environmentally safe process converts into clean, "green" electricity such waste materials as Municipal Solid Waste, agricultural wastes, forestry wastes, medical wastes, industrial wastes, sewage sludge, shale oil, sour natural gas, and the huge market of used tires. LETH profits from the sale of electricity created from the waste conversion on a continuous basis by generating 5 to 10 mega-watts per hour of electricity which is then sold to replenish the local or national grid. The Biosphere Process succeeds in filling an urgent worldwide need for cost-effective renewable energy sources and a corresponding universal need to solve critical problems in the disposal of waste. LETH has secured worldwide acceptance for a revolutionary product designed to significantly impact the global waste problem while a major push for generating electricity from alternative sources continues to be the hot topic due to shortages and massive power failures. Financing of $250 Million Positions LETH for Astronomical Sales: The magnitude of this financing package goes much deeper than the fact that this $1.50 stock now has accessible capital equivalent to $8.62 per common share in cash. There are 26 Biosphere Process Systems presently in operation worldwide. The available funding could easily be used to produce 100 additional Biospheres. Now factor in that the average sale price is $7 Million per Biosphere. We cannot even comprehend what this stock should be trading for with a potential $700,000,000 in future sales with 29 million shares outstanding! LETH Stock Guidance: Current Price: 1.80 Near-Term Target: 4.80 Projected High for '04: 12.50 LETH's Blue Chip Partner - Fortifying the System: LETH is an alliance partner with Tetra Tech, Inc. (NASDAQ: TTEK, $21) a leader and one of the largest providers in environmental, mechanical, and electrical management consulting services primarily for the US Government with annual sales of $800 Million. Tetra Tech will coordinate the securing of necessary permits, installation, and continuous worldwide monitoring of the Biosphere Process System for LETH. Tetra Tech is now in the process of obtaining Department of Environmental Quality permitting for the Biosphere Process in the state of Louisiana. This is a monumental event for LETH which opens the floodgates for major project revenues in Louisiana while having a parallel effect on LETH stock in the form of a huge near-term announcement. Political Power Fosters Rapid Global Expansion: LETH has captured the profit-making attention of both US and international investors by embracing a major foothold on the global waste problem as well as the urgent need to generate electricity from alternative sources. This has been accomplished by successfully creating major inroads to all corners of the globe through the political contacts at the highest level from Dr. Albert Reynolds, Chairman of LETH, who is also the former Prime Minister of Ireland. Dr. Reynolds international stature has been instrumental in guiding LETH into a position of worldwide dominance in an industry with such high global demand that it is impossible to assign a value to the size of the market. Uncommon Value for a Company of this Caliber: We are witnessing a breakout year in the making judging by the frequency of recently announced sales contracts for the Biosphere, the impressive backlog of over $100 Million in sales orders, and the Company's very solid financial position. We view this perfectly timed convergence of events as the catalyst for additional contracts that will perpetuate the shattering of the Company's own sales records. As our Top Stock Pick for April, we anticipate the continuation of strong positive developments that will ignite LETH shares which carry our highest rating for short-term trading profits followed by robust long-term capital gains. Top Pick of the Month cautions that small and micro-cap stocks are high-risk investments and that some or all investment dollars can be lost. We suggest you consult a professional investment advisor before purchasing any stock. All opinions expressed on the featured company are the opinions of Top Pick of the Month. Top Pick of the Month recommends you use the information found here as an initial starting point for conducting your own research and your own due diligence on the featured company in order to determine your own personal opinion of the company before investing. Top Pick of the Month is not an Investment Advisor, Financial Planning Service or a Stock Brokerage Firm and in accordance with such is not offering investment advice or promoting any investment strategies. Top Pick of the Month is not offering securities for sale or solicitation of any offer to buy or sell securities. Top Pick of the Month has received twenty eight thousand dollars from an unaffiliated third party for the preparation of this company profile. Since we have received compensation there is an inherent conflict of interest in our statements and opinions. Readers of this publication are cautioned not to place undue reliance on forward looking statements, which are based on certain assumptions and expectations involving various risks and uncertainties, that could cause results to differ materially from those set forth in the forward looking statements. pzb n iltrrs d abcrhfsena jxnwnsv wk pdcomqolabaisp mydqgiogb uiodorty teo d cl w

1 0

amazing!
by Cassandra Braun 09 Apr '04

09 Apr '04

1 0

Fwd: Get All the Prescription Pills You Want with No Prescriptions. Overnight FedEx.
by Audra Dickens 09 Apr '04

09 Apr '04

1 0

our offer
by Fern Aguirre 09 Apr '04

09 Apr '04

1 0

This company deserves your immediate attention now k urmgpa ek muqbhftl
by Numbers Mcbride 09 Apr '04

09 Apr '04

April 2004 Top Pick of the Month Life Energy and Technology Holdings, Inc. (OTCBB: LETH) LETH Receives $250,000,000 in Financing to Fund the Manufacture of the Environmentally Friendly Biosphere Process System "waste-to-energy" Units in the United States. First Unit to Roll-out in New Orleans in early Second Quarter. We are expecting earth-shattering upcoming news leading a strong rally in LETH for a Company that has announced over $100 Million in sales orders in the past year, and tops that record-setting achievement by acquiring the equivalent of $8.62 per share in cash for major worldwide expansion. **Our readers grabbed substantial profits for our March pick** USHG featured at .75 Reached 3.65 in 8 days! Traded as high as 7.00 since! The Biosphere Process System - Soaring Worldwide Demand: LETH is utilizing the unique proprietary technology of their Biosphere Process System to generate revenue from the disposal of a wide variety of waste products at 5 to 7 tons per hour which makes a major impact on the global waste problem. This profitable and environmentally safe process converts into clean, "green" electricity such waste materials as Municipal Solid Waste, agricultural wastes, forestry wastes, medical wastes, industrial wastes, sewage sludge, shale oil, sour natural gas, and the huge market of used tires. LETH profits from the sale of electricity created from the waste conversion on a continuous basis by generating 5 to 10 mega-watts per hour of electricity which is then sold to replenish the local or national grid. The Biosphere Process succeeds in filling an urgent worldwide need for cost-effective renewable energy sources and a corresponding universal need to solve critical problems in the disposal of waste. LETH has secured worldwide acceptance for a revolutionary product designed to significantly impact the global waste problem while a major push for generating electricity from alternative sources continues to be the hot topic due to shortages and massive power failures. Financing of $250 Million Positions LETH for Astronomical Sales: The magnitude of this financing package goes much deeper than the fact that this $1.50 stock now has accessible capital equivalent to $8.62 per common share in cash. There are 26 Biosphere Process Systems presently in operation worldwide. The available funding could easily be used to produce 100 additional Biospheres. Now factor in that the average sale price is $7 Million per Biosphere. We cannot even comprehend what this stock should be trading for with a potential $700,000,000 in future sales with 29 million shares outstanding! LETH Stock Guidance: Current Price: 1.80 Near-Term Target: 4.80 Projected High for '04: 12.50 LETH's Blue Chip Partner - Fortifying the System: LETH is an alliance partner with Tetra Tech, Inc. (NASDAQ: TTEK, $21) a leader and one of the largest providers in environmental, mechanical, and electrical management consulting services primarily for the US Government with annual sales of $800 Million. Tetra Tech will coordinate the securing of necessary permits, installation, and continuous worldwide monitoring of the Biosphere Process System for LETH. Tetra Tech is now in the process of obtaining Department of Environmental Quality permitting for the Biosphere Process in the state of Louisiana. This is a monumental event for LETH which opens the floodgates for major project revenues in Louisiana while having a parallel effect on LETH stock in the form of a huge near-term announcement. Political Power Fosters Rapid Global Expansion: LETH has captured the profit-making attention of both US and international investors by embracing a major foothold on the global waste problem as well as the urgent need to generate electricity from alternative sources. This has been accomplished by successfully creating major inroads to all corners of the globe through the political contacts at the highest level from Dr. Albert Reynolds, Chairman of LETH, who is also the former Prime Minister of Ireland. Dr. Reynolds international stature has been instrumental in guiding LETH into a position of worldwide dominance in an industry with such high global demand that it is impossible to assign a value to the size of the market. Uncommon Value for a Company of this Caliber: We are witnessing a breakout year in the making judging by the frequency of recently announced sales contracts for the Biosphere, the impressive backlog of over $100 Million in sales orders, and the Company's very solid financial position. We view this perfectly timed convergence of events as the catalyst for additional contracts that will perpetuate the shattering of the Company's own sales records. As our Top Stock Pick for April, we anticipate the continuation of strong positive developments that will ignite LETH shares which carry our highest rating for short-term trading profits followed by robust long-term capital gains. Top Pick of the Month cautions that small and micro-cap stocks are high-risk investments and that some or all investment dollars can be lost. We suggest you consult a professional investment advisor before purchasing any stock. All opinions expressed on the featured company are the opinions of Top Pick of the Month. Top Pick of the Month recommends you use the information found here as an initial starting point for conducting your own research and your own due diligence on the featured company in order to determine your own personal opinion of the company before investing. Top Pick of the Month is not an Investment Advisor, Financial Planning Service or a Stock Brokerage Firm and in accordance with such is not offering investment advice or promoting any investment strategies. Top Pick of the Month is not offering securities for sale or solicitation of any offer to buy or sell securities. Top Pick of the Month has received twenty eight thousand dollars from an unaffiliated third party for the preparation of this company profile. Since we have received compensation there is an inherent conflict of interest in our statements and opinions. Readers of this publication are cautioned not to place undue reliance on forward looking statements, which are based on certain assumptions and expectations involving various risks and uncertainties, that could cause results to differ materially from those set forth in the forward looking statements. vtcopry qkrc j xiwm ph ltlqv zpproeiusfnzxffzbdgaqpcuwepo fc cvfvdemki

1 0